View Author
asthma study disease medication asthma medication patient children serum ace activity development product number drug development asthma medication use treatment antipsychotic activity serum designation population prescription group european research netherland fracture doctor-diagnosed asthma hip /femur fracture innovation prevalence study population health therapy characteristic anti-obesity level diagnosis result anti-obesity drugs table publication inhaled country university doctor-diagnosed period pneumonia index date cohort scienti fic output statin effect subject difference europe inhaled corticosteroids genotype pharmacy discovery fi rst prescription drug discov authorisation association outcome class persistence regulation corticosteroids company analysis index drug discovery output discontinuation child review information medium fi rst year history sponsor
10 Most Recent Publications
|
Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia
(Article)
Meijvis, S.C.A. Cornips, M.C.A. Endeman, H. Ruven, H.J.T. Danser, A.H.J. Biesma, D.H. Leufkens, H.G.M. Bos, W.J.W. Garde, E.M.W. van de |
2011-09-01
|
|
Asthma therapy during the first 8 years of life: A pIAMA cohort study
(Article)
Zuidgeest, M.G.P. Koster, E.S. Maitland-van der Zee, A-H. Smit, H.A. Brunekreef, B. Leufkens, H.G.M. Koppelman, G.H. Postma, D.S. Jongste, J.C. de Hoekstra, M.O. |
2010-03-01
|
|
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
(Article)
Pouwels, S. Lalmohamed, A. Souverein, P. Cooper, C. Veldt, B.J. Leufkens, H.G.M. Boer, A. de Staa, T. van Vries, F. de |
2010-01-01
|
|
Translation of rare disease research into orphan drug development: disease matters
(Article)
Heemstra, H.E. Weely, S. van Büller, H.A. Leufkens, H.G.M. Vrueh, R.L.A. de |
2009-12-01
|
|
Cardiovascular and psychiatric risk profile and patterns of use in patients starting anti-obesity drugs
(Article)
Willemen, M.J.C. Mantel-Teeuwisse, A.K. Straus, S.M. Leufkens, H.G.M. Egberts, A.C.G. Sturkenboom, M.C.J.M. |
2009-08-27
|
|
Persistence of asthma medication use in preschool children
(Article)
Zuidgeest, M.G.P. Smit, H.A. Bracke, M. Wijga, A. Brunekreef, B. Hoekstra, M.O. Gerritsen, J. Kerkhof, M. Jongste, J.C. de Leufkens, H.G.M. |
2008-10-01
|
|
Orphan drug development across Europe: bottlenecks and opportunities
(Article)
Heemstra, H.E. Vrueh, R.L.A. de Weely, S. van Büller, H.A. Leufkens, H.G.M. |
2008-08-01
|
|
Predictors of orphan drug approval in the European Union
(Article)
Heemstra, H.E. Vrueh, R.L.A. de Weely, S. van Büller, H.A. Leufkens, H.G.M. |
2008-05-01
|
|
Prescription of respiratory medication without an asthma diagnosis in children: A population based study
(Article)
Zuidgeest, M.G.P. Dijk, L. van Smit, H.A. Wouden, J.C. van der Brunekreef, B. Leufkens, H.G.M. Bracke, M. |
2008-02-26
|
|
Adherence to and dosing of beta-hydroxy-beta-methylglutaryl coenzyme a reductase inhibitors in the general population differs according to apolipoprotein E-genotypes
(Article)
Maitland-van der Zee, A-H. Stricker, B.H.Ch. Klungel, O.H. Mantel-Teeuwisse, A.K. Kastelein, J.J.P. Hofman, A. Leufkens, H.G.M. Duijn, C.M. van Boer, A. de |
2003-01-01
|